Trial NCT01105390

View at ClinicalTrials.gov 
Org. Study IDs: E1B09
Secondary IDs: CDR0000670445 NCI-2011-02068 U10CA021115

Last trial update was posted on 2013-08-02

MeSH Interventions

Antibodies, Monoclonal Pemetrexed Rilotumumab

MeSH Conditions

Lung Neoplasms Mesothelioma Mesothelioma, Malignant

Other Conditions

Advanced Malignant Mesothelioma Epithelial Mesothelioma Recurrent Malignant Mesothelioma Sarcomatous Mesothelioma

Stopping Reasons

withdrawn

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID